Elite Pharmaceuticals, Inc. Financial Ratios — ELTP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-121.3	-136.28	13.88	-232.83	20.78	-2.37	11.55	-11.27	-33.57	-9.08	19.9	29.01	9.37	32.29	-4.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-3.53	- -	- -	- -	- -	- -	-3.4	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	-34.28	- -	- -	- -	- -	- -	11.5	- -	- -
Gross Margin (%)	37.29	58.18	31.98	29.67	39.91	64.12	38.8	52.93	37.89	44.34	46.76	45.86	48.58	46.55	47.7
EBITDA Margin (%)	-9.43	-61.14	-33.49	-104.97	-317.53	-61.21	-68.91	-107.99	-104.4	-4.31	14.3	20.16	15.56	21.73	27.75
Operating Margin (%)	-20.76	-81.11	-45.93	-114.83	-329.14	-66.54	-76.32	-121.35	-121.01	-12.7	8.29	15.72	11.62	19.05	25.23
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	59.43	43.1	-58.21	30.35	37.99
Pretax Margin (%)	-325.45	-641.15	33.32	-903.07	104.03	-9.63	20.17	-63.27	-131.54	-12.44	16.33	19.54	11.67	0.82	-0.06
Profit Margin (%)	-318.38	-621.19	43.72	-896.71	104.09	-5.46	39.54	-49.25	-122.6	-12.45	20.05	27.58	10.43	35.51	-5.13
Net Income to Common Margin (%)	-318.38	-621.19	43.72	-2,098.83	576.83	-79.76	254.47	-49.25	-122.6	-12.45	20.05	27.58	10.43	35.51	-5.13
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.64	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	57.28	81.95	93.15	84.46	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	3	4	4	4	3	3	4	4	4	2	3	4	12	11
ST Debt	- -	3	4	4	1	1	- -	1	1	2	1	1	- -	5	5
LT Debt	- -	- -	- -	- -	3	2	2	3	3	2	2	2	4	7	6
Total Debt/EBITDA	-0.05	-2.29	-3.5	-0.83	-0.23	-0.45	-0.4	-0.49	-0.5	-5.2	0.66	0.43	0.73	0.95	0.47
Net Debt/EBITDA	4.49	-1.84	-3.18	0.6	0.24	1.05	1.2	0.4	-0.22	-3.25	-0.29	-1.04	-0.75	0.04	-0.17
Total Debt/EBIT	-0.02	-1.73	-2.55	-0.76	-0.22	-0.41	-0.36	-0.44	-0.43	-1.76	1.13	0.55	0.98	1.09	0.51
Net Debt/EBIT	2.04	-1.39	-2.32	0.55	0.23	0.97	1.08	0.35	-0.19	-1.1	-0.49	-1.34	-1	0.04	-0.19
EBITDA to Interest Expense	-0.27	-2.27	-2.9	-5.37	-55.44	-27.26	-27.88	-24.01	-21.4	-2.18	13.98	33.91	4.78	20.91	30.2
EBITDA-CapEx/Interest Expense	-1.2	-3.29	-3.42	-5.99	-62.4	-34.2	-32.52	-24.83	-21.46	-2.28	12.71	31.32	-0.38	19.53	26.93
EBIT to Interest Expense	-0.59	-3.01	-3.98	-5.87	-57.47	-29.63	-30.88	-26.98	-24.81	-6.42	8.11	26.44	3.57	18.33	27.45
Interest Expense	1	1	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Common Equity/Total Assets	-972.87	-1,256.7	-1,151.06	-922.97	-545.33	-448.17	-401.98	-458.91	-618.73	-613.89	-564.92	-395.6	-331.29	-137.86	-124.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	976.27	19.49	8.42	18.03	- -	18.46	11.02	8.82	12.3	11.67	10.9
Long-Term Debt/Capital (%)	-0.01	- -	- -	-0.04	-2.56	-2.31	-1.6	-2.69	-2.26	-1.45	-1.22	-1.63	-2.71	-6.49	-5.36
Long-Term Debt/Total Assets (%)	0.06	- -	- -	0.36	10.13	6.87	6.3	10.79	13.63	7.88	6.8	6.33	8.71	8.03	6.05
Total Debt/Equity (%)	-0.11	-22.68	-46.02	-4.95	1,369.8	30.84	10.32	21.57	-158.72	37.8	14.73	11.03	13.42	20.38	20.4
Total Debt/Capital (%)	-0.02	-2.69	-3.22	-1.82	-3.59	-3.65	-1.96	-3.22	-2.71	-2.98	-1.63	-2.04	-2.95	-11.33	-10.04
Total Debt/Total Assets (%)	0.17	32.96	35.88	16.53	14.21	10.87	7.72	12.91	16.31	16.14	9.08	7.91	9.51	14.03	11.32
Net Debt to Equity	10.11	-18.22	-41.76	3.6	-1,405.88	-72.28	-30.96	-17.28	-67.9	23.66	-6.45	-26.93	-13.67	0.82	-7.54
Net Debt/Capital (%)	1.55	-2.15	-2.91	1.28	3.43	7.63	5.45	2.44	-1.14	-1.85	0.7	4.69	2.84	-0.42	3.36
EBITDA	- -	-1	-1	-5	-16	-8	-7	-8	-8	-1	4	7	5	12	23
EBITDA-CapEx	-2	-2	-1	-5	-18	-10	-8	-8	-8	-1	3	6	- -	11	21
Operating Income (Loss)	-1	-2	-2	-5	-17	-8	-7	-9	-9	-2	2	5	4	11	21

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.39	0.15	0.07	1.13	1.47	2.48	3.17	1.4	0.33	0.13	0.55	1.28	1	0.54	0.96
Current Ratio	0.67	0.33	0.47	1.61	2.43	3.6	5.5	2.68	1.28	1.19	2.1	2.82	2.75	3.07	4.88
Quick Ratio	0.51	0.23	0.19	1.25	1.76	2.81	3.45	1.54	0.52	0.61	1.15	1.73	1.39	2.04	3.42
CFO/Avg Current Liab	0.33	-0.09	-0.34	-0.73	-2.69	-0.57	-1.97	-1.14	-1.13	-0.23	0.44	1.04	0.46	-0.31	0.6
Common Equity/Total Assets	-972.87	-1,256.7	-1,151.06	-922.97	-545.33	-448.17	-401.98	-458.91	-618.73	-613.89	-564.92	-395.6	-331.29	-137.86	-124.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	976.27	19.49	8.42	18.03	- -	18.46	11.02	8.82	12.3	11.67	10.9
Long-Term Debt/Capital (%)	-0.01	- -	- -	-0.04	-2.56	-2.31	-1.6	-2.69	-2.26	-1.45	-1.22	-1.63	-2.71	-6.49	-5.36
Long-Term Debt/Total Assets (%)	0.06	- -	- -	0.36	10.13	6.87	6.3	10.79	13.63	7.88	6.8	6.33	8.71	8.03	6.05
Total Debt/Equity (%)	-0.11	-22.68	-46.02	-4.95	1,369.8	30.84	10.32	21.57	-158.72	37.8	14.73	11.03	13.42	20.38	20.4
Total Debt/Capital (%)	-0.02	-2.69	-3.22	-1.82	-3.59	-3.65	-1.96	-3.22	-2.71	-2.98	-1.63	-2.04	-2.95	-11.33	-10.04
Total Debt/Total Assets (%)	0.17	32.96	35.88	16.53	14.21	10.87	7.72	12.91	16.31	16.14	9.08	7.91	9.51	14.03	11.32
CFO/Total Liabilities	5.24	-1.56	-8.55	-4	-58.88	-13.48	-91.17	-38.76	-25.24	-12.54	31.82	65.56	27.97	-12.41	17.39
CFO/CapEx	1.12	-0.59	-8.28	-7.52	-7.56	-1.42	-7.14	-17.5	-355.08	-51.32	9.68	13.05	0.58	-4	2.95
Altman's Z-Score	-14.25	-19.06	-16.88	-16.92	-8.8	-1.81	1.88	-5.28	-11.29	-8.65	-5.24	-2.51	-2.21	3.14	6.95

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	8.74	5.01	6.41	6.59	4.6	8.4	7.82	9.27	7.58	6.63	6.68	9.84	11.1	5.02	3.45
Days Sales Outstanding	41.78	72.91	56.95	55.42	79.27	43.47	46.67	39.39	48.17	55.06	54.67	37.08	32.87	72.67	105.67
Inventory Turnover	2.69	2.2	2.78	1.97	1.21	1.42	1.21	0.62	1	2.31	2.95	2.97	2.16	2.69	3.01
Days Inventory Outstanding	135.6	165.86	131.09	185.57	300.64	257.45	300.42	588.07	365.46	157.76	123.64	122.81	169.31	135.55	121.11
Accounts Payable Turnover	0.72	0.26	2.82	2.15	1.47	1.83	6.32	1.47	2.85	6.53	11.47	16.26	10.51	13.04	16.67
Accounts Payable Turnover Days	504.45	1,400.16	129.58	169.55	248.4	199.5	57.75	247.95	128.19	55.89	31.81	22.44	34.74	27.99	21.9
Cash Conversion Cycle	-327.07	-1,161.38	58.46	71.45	131.52	101.42	289.34	379.52	285.44	156.93	146.5	137.44	167.44	180.23	204.88
Inventory to Cash Days	-93.82	-92.94	-74.15	-130.16	-221.37	-213.98	-253.76	-548.68	-317.29	-102.71	-68.97	-85.74	-136.44	-62.88	-15.45
Inventories	1	- -	1	2	3	3	6	5	5	4	5	7	10	13	16
Raw Materials	2	- -	1	2	3	3	6	4	4	3	4	5	5	7	10
Work In Process	- -	- -	1	- -	- -	- -	- -	- -	- -	1	1	1	2	2	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	2	4	5
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	8	23	28	190	148	209	126	80	81	58	57	35	29	158	465
- Cash & Cash Equivalents	2	1	- -	7	7	12	11	7	2	1	3	9	8	7	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	35	44	- -	14	- -	14	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	3	4	4	4	3	3	4	4	4	2	3	4	12	11
Enterprise Value	6	26	32	187	179	245	118	90	83	75	56	30	25	163	464
Total Capital	-115	-126	-124	-220	-103	-94	-135	-124	-147	-135	-146	-136	-132	-104	-109
Total Debt/Capital (%)	-0.02	-2.69	-3.22	-1.82	-3.59	-3.65	-1.96	-3.22	-2.71	-2.98	-1.63	-2.04	-2.95	-11.33	-10.04
Total Debt / EV	- -	0.13	0.13	0.02	0.02	0.01	0.02	0.04	0.05	0.05	0.04	0.09	0.15	0.07	0.02
EV/Sales	1.45	10.75	9.27	40.62	35.7	19.61	12.23	12.11	10.98	4.17	2.2	0.92	0.74	2.87	5.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.37	4.54	4.79	13.22	19.9
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.5	5.83	6.41	15.07	21.9
EV/Cash Flow to Firm	2.06	108.74	- -	- -	- -	- -	- -	- -	- -	- -	15.88	4.38	5.87	7.29	6.51
EV/Free Cash Flow to Firm	1.41	28.69	- -	- -	- -	- -	- -	- -	- -	- -	14.51	4.08	2.53	7.03	6.28
Diluted Market Cap	8	23	42	190	189	209	127	80	82	70	57	35	29	159	465
Diluted Enterprise Value	6	26	46	187	221	245	119	91	83	86	56	30	25	164	464
EV per Share	0.06	0.1	0.09	0.4	0.3	0.36	0.14	0.11	0.1	0.09	0.06	0.03	0.03	0.16	0.43
TTM Sales	4	2	3	5	5	12	10	7	8	18	25	32	34	57	84
TTM EBITDA	- -	-1	-1	-5	-16	-8	-7	-8	-8	-1	4	7	5	12	23
TTM Operating Income	-1	-2	-2	-5	-17	-8	-7	-9	-9	-2	2	5	4	11	21
TTM Cash Flow to Firm	3	- -	-1	-3	-15	-3	-8	-4	-6	-1	4	7	4	22	71
TTM Free Cash Flow to Firm	4	1	-1	-3	-13	-1	-7	-4	-6	-1	4	7	10	23	74

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	2.72	84.96	-28.31	-51.92	-14.45	-255.83	-18.69	-17.6	-12.05	-39.53	16.06	5.04	3.24	-65.64	46.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.5	5.83	6.41	15.07	21.9
Enterprise Value	6	26	32	187	179	245	118	90	83	75	56	30	25	163	464
Low Price	0.04	0.06	0.05	0.06	0.17	0.2	0.11	0.06	0.07	0.03	0.05	0.02	0.03	0.03	0.12
EV/Sales	1.45	10.75	9.27	40.62	35.7	19.61	12.23	12.11	10.98	4.17	2.2	0.92	0.74	2.87	5.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.37	4.54	4.79	13.22	19.9
Price/Earnings	- -	- -	18.77	- -	5.11	- -	5.13	- -	- -	- -	11.12	3.97	8.25	7.86	- -
Price/Earnings Average	-0.45	-1.89	24.98	-0.8	6.37	-18.49	7.08	-26.94	-8.07	-29.79	12.79	5.15	10.48	4.9	-87.76
Price/Earnings High	-0.74	-4.47	39.88	-4.65	10.42	-29.74	13.68	-54.18	-11.41	-52.01	18.53	6.81	14.79	10.6	-186.91
Price/Earnings Low	-0.29	-1.03	11.73	-0.29	3.47	-13.52	3.76	-13	-6.14	-11.15	9.27	2.27	7.65	1.41	-30.03
Price/Book Value	-0.07	-0.18	-0.22	-0.85	-1.05	-1.47	-0.91	-0.56	-0.54	-0.38	-0.38	-0.25	-0.22	-1.37	-3.88
Price/Book Value Average	-0.05	-0.22	-0.29	-0.34	-1.3	-1.3	-1.26	-0.7	-0.5	-0.44	-0.44	-0.33	-0.28	-0.85	-3.16
Price/Book Value High	-0.09	-0.52	-0.46	-2	-2.13	-2.09	-2.43	-1.4	-0.7	-0.76	-0.64	-0.44	-0.39	-1.85	-6.74
Price/Book Value Low	-0.03	-0.12	-0.14	-0.12	-0.71	-0.95	-0.67	-0.34	-0.38	-0.16	-0.32	-0.15	-0.2	-0.25	-1.08
Price/Tangible Book Value	-0.43	-1.49	-2.98	-2.17	-3.6	-5.28	6.54	-25.34	-8.91	-5.9	5.94	1.9	1.3	3.08	9.71
Price/Tangible Book Value Average	-0.33	-1.82	-3.97	-0.88	-4.48	-4.66	9.02	-31.5	-8.19	-6.75	6.84	2.47	1.65	1.92	7.91
Price/Tangible Book Value High	-0.54	-4.31	-6.33	-5.13	-7.33	-7.5	17.43	-63.35	-11.58	-11.79	9.91	3.26	2.33	4.16	16.84
Price/Tangible Book Value Low	-0.22	-1	-1.86	-0.32	-2.44	-3.41	4.79	-15.2	-6.23	-2.53	4.95	1.09	1.2	0.55	2.71
Price/Sales	1.88	9.62	8.21	41.26	29.47	16.72	13.05	10.67	10.76	3.24	2.23	1.09	0.86	2.79	5.53
Price/Sales Average	1.45	11.76	10.92	16.76	36.76	14.75	18.01	13.27	9.9	3.71	2.56	1.42	1.09	1.74	4.51
Price/Sales High	2.34	27.8	17.44	97.61	60.12	23.72	34.81	26.68	13.98	6.48	3.72	1.88	1.54	3.77	9.6
Price/Sales Low	0.94	6.41	5.13	6.04	20.04	10.78	9.57	6.4	7.53	1.39	1.86	0.63	0.8	0.5	1.54
Price/Cash Flow	5.15	-59.19	-16.49	-45.02	-9.79	-75.54	-15.96	-16.55	-11.99	-32.48	17.72	5.43	8.8	-48.84	62.33
Price/Cash Flow Average	3.98	-72.34	-21.95	-18.29	-12.21	-66.65	-22.02	-20.58	-11.03	-37.21	20.37	7.05	11.18	-30.46	50.79
Price/Cash Flow High	6.44	-170.99	-35.04	-106.51	-19.96	-107.22	-42.55	-41.38	-15.58	-64.96	29.53	9.32	15.78	-65.92	108.17
Price/Cash Flow Low	2.58	-39.46	-10.31	-6.59	-6.65	-48.74	-11.7	-9.93	-8.39	-13.92	14.76	3.11	8.16	-8.79	17.38
Price/Free Cash Flow Average	2.1	103.84	-37.69	-21.09	-18.02	-225.7	-25.79	-21.88	-11.09	-45.29	18.47	6.55	4.11	-40.94	37.94
Price/Free Cash Flow High	3.4	245.43	-60.16	-122.83	-29.48	-363.12	-49.83	-44.01	-15.67	-79.06	26.76	8.65	5.8	-88.59	80.8
Price/Free Cash Flow Low	1.36	56.64	-17.69	-7.6	-9.83	-165.05	-13.7	-10.56	-8.44	-16.94	13.38	2.88	3	-11.81	12.98
EV/Sales Average	1.02	12.89	11.99	16.13	42.98	17.64	17.19	14.7	10.12	4.64	2.53	1.24	0.98	1.82	4.5
EV/Sales High	1.92	28.92	18.5	96.97	66.35	26.62	33.98	28.12	14.21	7.41	3.68	1.7	1.43	3.85	9.59
EV/Sales Low	0.51	7.54	6.19	5.4	26.27	13.68	8.75	7.84	7.76	2.32	1.83	0.45	0.68	0.58	1.54
EV/EBITDA Average	-10.86	-21.08	-35.79	-15.36	-13.54	-28.83	-24.94	-13.62	-9.69	-107.83	17.71	6.17	6.28	8.38	16.22
EV/EBITDA High	-20.37	-47.31	-55.24	-92.39	-20.89	-43.49	-49.31	-26.04	-13.61	-172.08	25.76	8.44	9.17	17.7	34.56
EV/EBITDA Low	-5.46	-12.33	-18.49	-5.15	-8.27	-22.35	-12.69	-7.26	-7.43	-53.91	12.77	2.22	4.39	2.69	5.54
EV/EBIT Average	-4.93	-15.89	-26.1	-14.04	-13.06	-26.52	-22.52	-12.12	-8.36	-36.56	30.53	7.91	8.41	9.56	17.84
EV/EBIT High	-9.25	-35.66	-40.28	-84.45	-20.16	-40.01	-44.52	-23.17	-11.74	-58.34	44.42	10.82	12.28	20.19	38.01
EV/EBIT Low	-2.48	-9.3	-13.48	-4.71	-7.98	-20.56	-11.46	-6.46	-6.41	-18.28	22.02	2.85	5.87	3.06	6.09
Last Price	0.08	0.09	0.08	0.41	0.25	0.31	0.15	0.1	0.1	0.07	0.06	0.03	0.03	0.16	0.44
High Price	0.1	0.26	0.17	0.97	0.51	0.44	0.4	0.25	0.13	0.14	0.1	0.06	0.05	0.21	0.75
Enterprise Value Average	4	31	41	74	216	221	166	110	77	84	64	40	33	103	378
Enterprise Value High	8	70	63	446	333	333	328	210	108	133	93	55	49	218	806
Enterprise Value Low	2	18	21	25	132	171	84	58	59	42	46	14	23	33	129

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	181	332	374	560	631	711	928	803	825	840	1,009	1,011	1,014	1,068	1,068
Diluted Weighted Avg Shares	100	259	527	463	758	674	845	798	816	993	943	1,011	1,013	1,023	1,068
Basic Weighted Avg Shares	100	259	349	463	591	674	839	796	814	832	943	1,011	1,013	1,015	1,068
Revenue per Share	0.04	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.02	0.03	0.03	0.03	0.06	0.08
EBITDA per Share	- -	-0.01	- -	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	0.01	0.01	0.02
Operating Income per Share	-0.01	-0.01	- -	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	- -	0.01	0.02
Basic EPS, GAAP	-0.14	-0.06	- -	-0.21	0.05	-0.01	0.03	- -	-0.01	- -	0.01	0.01	- -	0.02	- -
Basic EPS from Cont Ops	-0.14	-0.06	- -	-0.09	0.01	- -	- -	- -	-0.01	- -	0.01	0.01	- -	0.02	- -
Diluted EPS, GAAP	-0.14	-0.06	- -	-0.21	0.04	-0.01	0.03	- -	-0.01	- -	0.01	0.01	- -	0.02	- -
Diluted EPS from Cont Ops	-0.14	-0.06	- -	-0.09	0.01	- -	- -	- -	-0.01	- -	0.01	0.01	- -	0.02	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.02	- -	- -	-0.01	-0.03	- -	-0.01	-0.01	-0.01	- -	- -	0.01	- -	- -	0.01
Free Cash Flow per Basic Share	- -	- -	-0.01	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	- -	- -	- -
Cash & Equivalents per Share	0.02	- -	- -	0.01	0.01	0.02	0.01	0.01	- -	- -	- -	0.01	0.01	0.01	0.01
Book Value per Share	-1.15	-0.5	-0.37	-0.48	-0.24	-0.21	-0.16	-0.18	-0.19	-0.18	-0.16	-0.14	-0.13	-0.11	-0.11
Tangible Book Value per Share	-0.18	-0.06	-0.03	-0.19	-0.07	-0.06	0.02	- -	-0.01	-0.01	0.01	0.02	0.02	0.05	0.04

Elite Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)